In vivo anti-melanoma activities of the Melan-A/MART -1₁₀₁-₁₁₅ T CD4+ cell peptideBALASSE, Emilie; GATOUILLAT, Gregory; PATIGNY, Dominique et al.Vaccine. 2009, Vol 27, Num 44, pp 6107-6109, issn 0264-410X, 3 p.Article

Differential expression of MART-1, tyrosinase, and SM5-1 in primary and metastatic melanomaREINKE, Susanne; KÖNIGER, Peter; HERBERTH, Gunda et al.The American journal of dermatopathology. 2005, Vol 27, Num 5, pp 401-406, issn 0193-1091, 6 p.Article

Minimally invasive staging of patients with melanoma : Sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction. Commentary. Author's replyGOYDOS, J. S; RAVIKUMAR, T. S; GERMINO, F. J et al.Journal of the American College of Surgeons. 1998, Vol 187, Num 2, pp 182-190, issn 1072-7515Conference Paper

Expression of melanoma-associated antigens in melanoma cell culturesUROSEVIC, Mirjana; BRAUN, Bettina; WILLERS, Jörg et al.Experimental dermatology. 2005, Vol 14, Num 7, pp 491-497, issn 0906-6705, 7 p.Article

Polymerase chain reaction detection of melanoma cells in the circulation : Relation to clinical stage, surgical treatment, and recurrence from melanomaCURRY, B. J; MYERS, K; HERSEY, P et al.Journal of clinical oncology. 1998, Vol 16, Num 5, pp 1760-1769, issn 0732-183XArticle

Primary melanoma tumour regression associated with an immune response to the tumour-associated antigen melan-A/MART-1SALEH, Farid H; CROTTY, Kerry A; HERSEY, Peter et al.International journal of cancer. 2001, Vol 94, Num 4, pp 551-557, issn 0020-7136Article

Differential expression of MART-1 in primary and metastatic melanoma lesionsKAGESHITA, T; KAWAKAMI, Y; HIRAI, S et al.Journal of immunotherapy with emphasis on tumor immunology. 1997, Vol 20, Num 6, pp 460-465, issn 1067-5582Article

A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomasBERGMAN, R; AZZAM, H; SPECHER, E et al.Journal of the American Academy of Dermatology. 2000, Vol 42, Num 3, pp 496-500, issn 0190-9622Article

Stealth Melanoma Cells in Histology-negative Sentinel Lymph NodesITAKURA, Eijun; HUANG, Rong-Rong; WEN, Duan-Ren et al.The American journal of surgical pathology. 2011, Vol 35, Num 11, pp 1657-1665, issn 0147-5185, 9 p.Article

Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanomaBERSET, Magali; CEROTTINI, Jean-Philippe; GUGGISBERG, David et al.International journal of cancer. 2001, Vol 95, Num 1, pp 73-77, issn 0020-7136Article

Vaginal melanoma. A clinicopathologic and immunohistochemical study of 26 casesGUPTA, Deepali; MALPICA, Anais; DEAVERS, Michael T et al.The American journal of surgical pathology. 2002, Vol 26, Num 11, pp 1450-1457, issn 0147-5185, 8 p.Article

Retroviral transduction of human dendritic cells with a tumor-associated antigen geneREEVES, M. E; ROYAL, R. E; LAM, J. S et al.Cancer research (Baltimore). 1996, Vol 56, Num 24, pp 5672-5677, issn 0008-5472Article

MART-1 Is a Reliable Melanocytic Marker in Lichen Planus―Like Keratosis: A Study on 70 CasesGAVINO, Alde Carlo P; WOODS, Matthew T; ANDEA, Aleodor A et al.The American journal of dermatopathology. 2011, Vol 33, Num 7, pp 675-680, issn 0193-1091, 6 p.Article

Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cellsHAGGERTY, Timothy J; DUNN, Ian S; ROSE, Lenora B et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 1, pp 133-144, issn 0340-7004, 12 p.Article

Expression of Sox-9 in Metastatic Melanoma: A Potential Diagnostic PitfallRAO, Priya; FULLER, Gregory N; PRIETO, Victor G et al.The American journal of dermatopathology. 2010, Vol 32, Num 3, pp 262-266, issn 0193-1091, 5 p.Article

HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanomaZUBOVITS, Judit; BUZNEY, Elizabeth; YU, Lawrence et al.Human pathology. 2004, Vol 35, Num 2, pp 217-223, issn 0046-8177, 7 p.Article

Melan-A/MART-1 antigen expression in cutaneous and ocular melanomasNICOTRA, M. R; NISTICO, P; MANGONI, A et al.Journal of immunotherapy with emphasis on tumor immunology. 1997, Vol 20, Num 6, pp 466-469, issn 1067-5582Article

A Rare Case of a Cutaneous Squamomelanocytic Tumor: Revisiting the Histogenesis of Combined NeoplasmsMITEVA, Mariya; HERSCHTHAL, David; RICOTTI, Carlos et al.The American journal of dermatopathology. 2009, Vol 31, Num 6, pp 599-603, issn 0193-1091, 5 p.Article

Malignant melanoma involving the ovary: A clinicopathologic and immunohistochemical study of 23 casesGUPTA, Deepali; DEAVERS, Michael T; SILVA, Elvio G et al.The American journal of surgical pathology. 2004, Vol 28, Num 6, pp 771-780, issn 0147-5185, 10 p.Article

Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansionGOFF, Stephanie L; JOHNSON, Laura A; BLACK, Mary A et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 10, pp 1551-1560, issn 0340-7004, 10 p.Article

Monophosphoryl lipid A plus IFNγ maturation of dendritic cells induces antigen-specific CD8⁺ cytotoxic T cells with high cytolytic potentialTEN BRINKE, Anja; VAN SCHIJNDEL, Gijs; VISSER, Remco et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 8, pp 1185-1195, issn 0340-7004, 11 p.Article

Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patientsBINS, Adriaan; MALLO, Henk; SEIN, Johan et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 2, pp 234-239, issn 1524-9557, 6 p.Article

Phase 1 Trial of Intranodal Injection of a Melan-A/MART-1 DNA Plasmid Vaccine in Patients With Stage IV MelanomaWEBER, Jeffrey; BOSWELL, William; BOT, Adrian et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 2, pp 215-223, issn 1524-9557, 9 p.Article

Recurrent perivascular epithelioid cell tumor of the uterus (PEComa): an immunohistochemical study and review of the literatureGREENE, Laura A; MOUNT, Sharon L; SCHNED, Alan R et al.Gynecologic oncology (Print). 2003, Vol 90, Num 3, pp 677-681, issn 0090-8258, 5 p.Article

Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A and gp100 in metastatic melanoma lesions: Implications for immunotherapyCORMIER, J. N; ABATI, A; FETSCH, P et al.Journal of immunotherapy with emphasis on tumor immunology. 1998, Vol 21, Num 1, pp 27-31, issn 1067-5582Article